Trial intelligence / Profile preview

Antithrombotic regimens for left ventricular thrombus after acute myocardial infarction

2011-004265-32Phase 4Active

Sponsor
Academic Medical Center
Start
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of acenocoumarol in Left ventricular thrombosis (LVT) and myocardial infarction (MI) (2 arms), sponsored by Academic Medical Center. Primary endpoint: New cerebral microinfarcts at 6 months. Started Nov 2011; status: active.

02

Drugs

acenocoumarol
03

Conditions

Left ventricular thrombosis (LVT)myocardial infarction (MI)

Beyond the preview

Go deeper on 2011-004265-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-004265-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call